Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lightfoote

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biochemical Society Transactions|May 1, 1992
A drug-sensitizing RNA interaction of HIV-1 reverse transcriptaseJ M Bailey, M Lightfoote
AIDS Research and Human Retroviruses|March 1, 1996
Cupric and ferric ions inactivate HIVJ L Sagripanti, M M Lightfoote
Biochemical Society Transactions|August 1, 1994
Synthesis and antiviral properties of sterol phosphonoformatesJ M Bailey, M Lightfoote, E Lillehoj, et al.
Virology Journal|June 23, 2009
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeresYoshihiko Murata, Paula M Lightfoote, Robert C Rose, et al.
Biochemical Society Transactions|February 27, 1999
Antiviral action & tissue uptake of AZT-sterol dicarboxylatesJ M Bailey, K A Nelson, M Lightfoote, et al.
Clinical and Vaccine Immunology : CVI|February 19, 2010
Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata, Paula M Lightfoote, Ann R Falsey, et al.
Immunological Investigations|August 1, 1985
Circulating IgA immune complexes in AIDSM M Lightfoote, T M Folks, R Redfield, et al.
Journal of Biomedical Materials Research. Part A|March 28, 2013
Different molecular weight hyaluronic acid effects on human macrophage interleukin 1β productionLarissa F Baeva, Daniel B Lyle, Maria Rios, et al.
Vaccine|July 27, 2010
Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata, Paula M Lightfoote, Jamie N Biear, et al.
Science (New York, N.Y.)|February 7, 1986
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latencyT Folks, D M Powell, M M Lightfoote, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biochemical Society Transactions|May 1, 1992
A drug-sensitizing RNA interaction of HIV-1 reverse transcriptaseJ M Bailey, M Lightfoote
AIDS Research and Human Retroviruses|March 1, 1996
Cupric and ferric ions inactivate HIVJ L Sagripanti, M M Lightfoote
Biochemical Society Transactions|August 1, 1994
Synthesis and antiviral properties of sterol phosphonoformatesJ M Bailey, M Lightfoote, E Lillehoj, et al.
Virology Journal|June 23, 2009
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeresYoshihiko Murata, Paula M Lightfoote, Robert C Rose, et al.
Biochemical Society Transactions|February 27, 1999
Antiviral action & tissue uptake of AZT-sterol dicarboxylatesJ M Bailey, K A Nelson, M Lightfoote, et al.
Clinical and Vaccine Immunology : CVI|February 19, 2010
Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata, Paula M Lightfoote, Ann R Falsey, et al.
Immunological Investigations|August 1, 1985
Circulating IgA immune complexes in AIDSM M Lightfoote, T M Folks, R Redfield, et al.
Journal of Biomedical Materials Research. Part A|March 28, 2013
Different molecular weight hyaluronic acid effects on human macrophage interleukin 1β productionLarissa F Baeva, Daniel B Lyle, Maria Rios, et al.
Vaccine|July 27, 2010
Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata, Paula M Lightfoote, Jamie N Biear, et al.
Science (New York, N.Y.)|February 7, 1986
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latencyT Folks, D M Powell, M M Lightfoote, et al.
Pageof 2